ITC Q1 profit slides 27% as lower revenue, margin pressure hurt growth; misses estimates

ITC Q1 profit slides 27% as lower revenue, margin pressure hurt growth; misses estimates

Diversified conglomerate ITC Ltd on Friday (July 31) reported a standalone net profit of ₹3,578.8 crore for the first quarter, down 27.1% year-on-year from ₹4,912 crore in the corresponding quarter last year. The company’s revenue declined 14.4% to ₹16,908 crore from ₹19,761 crore a year ago. At the operating level, earnings before interest, taxes, depreciation…

Read More
Maruti Suzuki Q1 Results: Revenue accelerates 36%, but margins disappoint Street

Maruti Suzuki Q1 Results: Revenue accelerates 36%, but margins disappoint Street

Maruti Suzuki India reported a mixed set of standalone earnings for the June quarter, with better-than-expected profit offset by a sharp miss on operating performance as margins came under pressure despite robust revenue growth. For the quarter ended June 30, 2026, India’s largest carmaker reported a standalone net profit of ₹3,352 crore, down 10.8% from…

Read More
Novo Nordisk shares tumble after heart drug misses key late-stage trial endpoint

Novo Nordisk shares tumble after heart drug misses key late-stage trial endpoint

Novo Nordisk shares fell sharply on Friday after the Danish drugmaker said its late-stage trial of the experimental heart medicine ziltivekimab failed to reduce major adverse cardiovascular events (MACE) compared with a placebo. The drug showed some biological activity, but Novo Nordisk said it did not produce a statistically significant reduction in MACE, which was…

Read More
IOC swings to ₹2,661 crore loss in Q1 despite higher fuel sales as refining margins collapse

IOC swings to ₹2,661 crore loss in Q1 despite higher fuel sales as refining margins collapse

Indian Oil Corporation (IOC) reported a standalone net loss of ₹2,661.3 crore for the quarter ended June, significantly worse than the CNBC-TV18 poll estimate of a ₹1,824-crore loss. The company had reported a profit of ₹11,377 crore in the March quarter, highlighting the sharp deterioration in earnings over just one quarter. The June quarter was…

Read More
Zee shareholders approve ₹3,144 crore promoter fund infusion, ESOP plan

Zee shareholders approve ₹3,144 crore promoter fund infusion, ESOP plan

Shareholders of Zee Entertainment Enterpriseshave approved resolutions to raise ₹3,143.5 crore through the preferential issue of fully convertible warrants to a promoter group entity. The approval was secured at the company’s Extraordinary General Meeting (EGM). Under the proposal, Zee will issue 24,94,85,563 fully convertible warrants at ₹126 per warrant. The fund infusion will provide the…

Read More
Lupin gets tentative US FDA nod for a generic prostate cancer drug

Lupin gets USFDA approval for Diazepam Injection targeting $77.9 million US market

Pharmaceutical major Lupin Ltd on Friday (July 31) said it has received approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Diazepam Injection USP, 10 mg/2 mL (5 mg/mL), single-dose prefilled syringes. The USFDA approved Lupin’s product as bioequivalent to the reference listed drug (RLD) Valium Injection…

Read More